ID

22550

Description

ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00350051

Lien

https://clinicaltrials.gov/show/NCT00350051

Mots-clés

  1. 07/06/2017 07/06/2017 -
Téléchargé le

7 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT00350051

Eligibility Prostate Cancer NCT00350051

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
must have evidence of confirmed metastatic prostate cancer
Description

Metastatic Prostate Carcinoma Evidence of

Type de données

boolean

Alias
UMLS CUI [1,1]
C0936223
UMLS CUI [1,2]
C0332120
serum testosterone must be less than 50 ng/ml
Description

Serum testosterone measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0428413
disease must be progressing despite anti-androgen therapy
Description

Antiandrogen therapy | Disease Progression

Type de données

boolean

Alias
UMLS CUI [1]
C0279492
UMLS CUI [2]
C0242656
psa level must be elevated
Description

Raised prostate specific antigen

Type de données

boolean

Alias
UMLS CUI [1]
C0178415
additional criteria determined at screening visit
Description

Inclusion Criteria Additional

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1524062
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any previous cytotoxic chemotherapy for prostate cancer
Description

Cytotoxic Chemotherapy Prostate carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C0600139
use of any investigational drug in the last 4 weeks
Description

Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
symptomatic brain tumors requiring radiation to the brain
Description

Brain Neoplasms Symptomatic | Radiotherapy to brain Patient need for

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006118
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C0948319
UMLS CUI [2,2]
C0686904
active infection
Description

Communicable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0009450
additional criteria determined at screening visit
Description

Exclusion Criteria Additional

Type de données

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1524062

Similar models

Eligibility Prostate Cancer NCT00350051

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Metastatic Prostate Carcinoma Evidence of
Item
must have evidence of confirmed metastatic prostate cancer
boolean
C0936223 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
Serum testosterone measurement
Item
serum testosterone must be less than 50 ng/ml
boolean
C0428413 (UMLS CUI [1])
Antiandrogen therapy | Disease Progression
Item
disease must be progressing despite anti-androgen therapy
boolean
C0279492 (UMLS CUI [1])
C0242656 (UMLS CUI [2])
Raised prostate specific antigen
Item
psa level must be elevated
boolean
C0178415 (UMLS CUI [1])
Inclusion Criteria Additional
Item
additional criteria determined at screening visit
boolean
C1512693 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Cytotoxic Chemotherapy Prostate carcinoma
Item
any previous cytotoxic chemotherapy for prostate cancer
boolean
C0677881 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
Investigational New Drugs
Item
use of any investigational drug in the last 4 weeks
boolean
C0013230 (UMLS CUI [1])
Brain Neoplasms Symptomatic | Radiotherapy to brain Patient need for
Item
symptomatic brain tumors requiring radiation to the brain
boolean
C0006118 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0948319 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Exclusion Criteria Additional
Item
additional criteria determined at screening visit
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial